周一，H.C. Wainwright重申了对Oncolytics Biotech (NASDAQ: ONCY )股票的买入评级，目标价维持在5.00美元。该股目前交易价格为0.73美元，接近52周低点，根据 InvestingPro 的公允价值计算，显示出潜在上涨空间。值得注意的是，尽管该公司过去一年的股票表现显示-36.61%的回报率，分析师仍维持4.73美元的高目标价。该公司分析师Pat ...

The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the U.S. common stocks listed on the NYSE, AMEX, ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Biotechnology industry for Monday, February 03, 2025. Let’s ...

Don’t look now, but Cathie Wood of Ark Invest is fresh off an impressive comeback year, with her broader basket of disruptive ...

When the company reported VK2735's phase 2 results last year, the stock jumped 121% in one trading session. Viking gave back ...

The biotech scene can be seen as fairly risky for new investors who want to put money to work. After all, it’s really tough ...

Curie.Bio, the biotech accelerator and investment firm, has raised another $340 million to invest in startups.

H.C. Wainwright reaffirmed a Buy rating on Oncolytics Biotech (NASDAQ:ONCY) shares with a steady price target of $5.00. The stock, currently trading at $0.73 and near its 52-week low, shows potential ...

华盛顿州西雅图 - 专门从事实验室分析仪器的Nautilus Biotechnology, Inc. (NASDAQ: NAUT )在最近向美国证券交易委员会 (SEC)提交的文件中披露，其两名董事会成员将不会寻求连任。这一消息公布之际，该公司股票在过去一周下跌了7.81%，目前交易价格接近其52周低点1.61美元。

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

The UK biotech sector raised £3.5bn in 2024, marking a 94% increase from the previous year, according to the BioIndustry ...

Global asset manager GordonMD Global Investments and South Korea’s biotech-focused venture capital firm Partners Investment have joined forces to launch a co-managed fund for biotech investments. The ...